Bone Therapeutics SA (BOTHE) | Stock Overview & Key Data
Bone Therapeutics SA Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €28.90 on February 9, 2015
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bone Therapeutics SA
BOTHE
|
N/A Micro-cap | N/A | N/A | N/A | N/A | N/A | -80.00% | -98.25% | -99.73% | -99.95% | -99.95% | -99.95% |
|
SD Worx SA
BE0002655364
|
N/A Micro-cap | 0.09% | 0.08% | 0.31% | 0.16% | 0.27% | -0.36% | 0.54% | -3.43% | -3.43% | -3.43% | -3.43% |
|
Fluvius System
EAN25
|
N/A Micro-cap | 0.00% | 0.00% | 0.38% | 0.38% | 0.38% | 1.59% | 2.28% | 2.28% | 2.28% | 2.28% | 2.28% |
|
CONTINENTAL LAND
NL0000121622
|
N/A Micro-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -9.91% | -9.91% | -9.91% | -9.91% | -9.91% | -9.91% |
|
VDK BANK
BE0022780820
|
N/A Micro-cap | 0.00% | 0.00% | 8.33% | -2.50% | -2.50% | -6.59% | 4.70% | -7.14% | -7.14% | -7.14% | -7.14% |
|
Kingdom of Belgium
B304
|
N/A Micro-cap | 1.01% | 1.13% | 0.14% | -1.01% | -0.51% | -3.74% | -5.67% | 82.34% | 82.34% | 198.96% | 198.96% |
Ownership & Short Interest
Calculate Your Bone Therapeutics SA Investment Returns
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BOTHE's 52-week high and low?
- In the last 52 weeks, Bone Therapeutics SA reached a high of €0.00 (on June 12, 2026) and a low of €0.00 (on June 12, 2026).
- What is the market cap and P/E ratio for BOTHE?
- Curious about Bone Therapeutics SA's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.00, and the forward P/E (looking ahead) is N/A.
- Does BOTHE pay dividends? If so, what's the yield?
- As for dividends, Bone Therapeutics SA isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Bone Therapeutics SA's main competitors or similar companies to consider before investing?
When looking at Bone Therapeutics SA, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return SD Worx SA
BE0002655364N/A N/A N/A -0.36% 0.54% Fluvius System
EAN25N/A N/A N/A 1.59% 2.28% CONTINENTAL LAND
NL0000121622N/A N/A N/A -9.91% -9.91% VDK BANK
BE0022780820N/A N/A N/A -6.59% 4.70% Kingdom of Belgium
B304N/A N/A N/A -3.74% -5.67% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bone Therapeutics SA? (e.g., ROE, Debt/Equity)
- To get a sense of Bone Therapeutics SA's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.88%, the Debt to Equity ratio from the most recent quarter is -0.25, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BOTHE?
- Looking at Bone Therapeutics SA's growth, its revenue over the trailing twelve months (TTM) was €1M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of BOTHE stock is held by insiders and institutions?
- Wondering who owns Bone Therapeutics SA stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.